Tiba is a Boston-based biotechnology startup with a mission to create a new generation of vaccines and immunotherapies for human and animal disease. We bridge expertise in synthetic biology and chemistry to bring a safer, more potent, and more cost-effective product to the market.
Our vision is a world where vaccines and therapeutics are cheap to develop and deploy in response to epidemics and specific patient needs, without the need for protracted biomanufacturing processes. Contact us today to learn more about our technology and partnership opportunities.